Have You experienced a side effect?
and Vote

Yes, Severe
Yes, Moderate
Yes, Minor
No
Discuss Results
1.5 million people annually are harmed from drug errors. Side Effects Reported Today:

Don't Risk Your Health!
Ask a Health Expert Now

"The greatest wealth is health."         - Virgil


      Advertisement

INJECTION SITE CELLULITIS side effect

What is INJECTION SITE CELLULITIS ?
Health Expert

A Health Expert wants to answer your question.

Please provide details below.



Drugs associated with INJECTION SITE CELLULITIS

AVONEX  BETASERON  BONIVA  BYETTA  CAMPATH  CLINDAMYCIN  DALTEPARIN  DELESTROGEN  DEXTROSE  ENBREL  FASLODEX  HUMIRA  HYDROXYZINE  HYDROXYZINEECTIO MAGNEVIST  NOVOLOG  RAPTIVA  REBIF  RISPERDAL  SANDOSTATIN  VIDAZA  


INJECTION SITE CELLULITIS : Rebif Side Effects Report #5664192-9
Consumer or non-health professional from UNITED STATES reported REBIF problem on Feb 28, 2008. Female patient, 22 years of age, was diagnosed with multiple sclerosis and was treated with REBIF. After drug was administered, patient experienced the following problems/side effects: injection site cellulitis, . REBIF dosage: unknown. During the same period patient was treated with ANTIBIOTICS. Patient was hospitalized. Patient recovered.

INJECTION SITE CELLULITIS : Dextrose Side Effects Report #5669851-X
DEXTROSE problem was reported by a Pharmacist from HONG KONG on Feb 18, 2008. Female patient, weighting 22.05 lb, was diagnosed with fluid replacement, pyrexia and was treated with DEXTROSE. After drug was administered, patient experienced the following problems/side effects: injection site cellulitis, injection site haemorrhage, . DEXTROSE dosage: unknown. During the same period patient was treated with PANADOL. Patient was hospitalized. Patient recovered.

INJECTION SITE CELLULITIS : Magnevist Side Effects Report #5674024-0
Health Professional from UNITED STATES reported MAGNEVIST SINGLE problem on Mar 04, 2008. Female patient, 39 years of age, weighting 244.7 lb, was diagnosed with nuclear magnetic resonance imaging brain and was treated with MAGNEVIST SINGLE. After drug was administered, patient experienced the following problems/side effects: injection site cellulitis, injection site phlebitis, vessel puncture site pain, . MAGNEVIST SINGLE dosage: unknown. Patient recovered.

INJECTION SITE CELLULITIS : Betaseron Side Effects Report #5677251-1
BETASERON problem was reported by a Consumer or non-health professional from UNITED STATES on Mar 10, 2008. Female patient, 58 years of age, was diagnosed with multiple sclerosis and was treated with BETASERON. After drug was administered, patient experienced the following problems/side effects: injection site cellulitis, injection site discomfort, injection site erythema, injection site swelling, . BETASERON dosage: unknown. During the same period patient was treated with DETROL, FOSAMAX, SYNTHROID. Patient was hospitalized. Patient recovered.

INJECTION SITE CELLULITIS : Rebif Side Effects Report #5677880-5
Consumer or non-health professional from UNITED STATES reported REBIF problem on Mar 07, 2008. Female patient, 22 years of age, weighting 104.7 lb, was diagnosed with multiple sclerosis and was treated with REBIF. After drug was administered, patient experienced the following problems/side effects: injection site cellulitis, injection site discharge, . REBIF dosage: unknown. Patient was hospitalized. Patient recovered.

INJECTION SITE CELLULITIS : Rebif Side Effects Report #5689661-7
REBIF problem was reported by a Consumer or non-health professional from UNITED STATES on Mar 18, 2008. Male patient, 45 years of age, was diagnosed with multiple sclerosis and was treated with REBIF. After drug was administered, patient experienced the following problems/side effects: injection site cellulitis, . REBIF dosage: unknown. Patient was hospitalized. Patient recovered.

INJECTION SITE CELLULITIS : Rebif Side Effects Report #5619109-X
Consumer or non-health professional from UNITED STATES reported REBIF problem on Jan 23, 2008. Female patient, 61 years of age, weighting 140.0 lb, was diagnosed with multiple sclerosis and was treated with REBIF. After drug was administered, patient experienced the following problems/side effects: injection site cellulitis, injection site pain, . REBIF dosage: unknown. During the same period patient was treated with PROCARDIA, SLEEPING S. Patient was hospitalized. Patient recovered.

INJECTION SITE CELLULITIS : Campath Side Effects Report #5627712-6
CAMPATH problem was reported by a Health Professional from UNITED STATES on Feb 12, 2008. Male patient, 62 years of age, weighting 178.6 lb, was diagnosed with chronic lymphocytic leukaemia and was treated with CAMPATH. After drug was administered, patient experienced the following problems/side effects: injection site cellulitis, injection site erythema, injection site oedema, injection site warmth, . CAMPATH dosage: AS USED: 3 MG. During the same period patient was treated with DECADRON, LEVAQUIN, BACTRIM DS. Patient was hospitalized. Patient recovered.

INJECTION SITE CELLULITIS : Boniva Side Effects Report #5630444-1
Physician from UNITED STATES reported BONIVA problem on Feb 08, 2008. Female patient, weighting 107.6 lb, was treated with BONIVA. After drug was administered, patient experienced the following problems/side effects: injection site cellulitis, . BONIVA dosage: unknown. Patient recovered.

INJECTION SITE CELLULITIS : Novolog Side Effects Report #5632888-0
NOVOLOG problem was reported by a Physician from UNITED STATES on Feb 12, 2008. Male patient, 34 years of age, was diagnosed with insulin-requiring type 2 diabetes mellitus and was treated with NOVOLOG. After drug was administered, patient experienced the following problems/side effects: injection site cellulitis, . NOVOLOG dosage: unknown. Patient was hospitalized. Patient recovered.

INJECTION SITE CELLULITIS : Vidaza Side Effects Report #5603369-5
Pharmacist from GERMANY reported VIDAZA problem on Jan 10, 2008. Male patient was diagnosed with myelodysplastic syndrome and was treated with VIDAZA. After drug was administered, patient experienced the following problems/side effects: injection site cellulitis, injection site nodule, vasculitis necrotising, . VIDAZA dosage: (75 MG/M2), SUBCUTANEOUS. Patient was hospitalized. Patient recovered.

INJECTION SITE CELLULITIS : Enbrel Side Effects Report #5552627-1
ENBREL problem was reported by a Health Professional from UNITED STATES on June 21, 2007. Male patient was diagnosed with polyarthritis and was treated with ENBREL. After drug was administered, patient experienced the following problems/side effects: injection site cellulitis, . ENBREL dosage: unknown. Patient recovered.

INJECTION SITE CELLULITIS : Enbrel Side Effects Report #5561267-X
Consumer or non-health professional from UNITED STATES reported ENBREL problem on Oct 25, 2007. Female patient was diagnosed with rheumatoid arthritis and was treated with ENBREL. After drug was administered, patient experienced the following problems/side effects: injection site cellulitis, . ENBREL dosage: unknown. During the same period patient was treated with METHOTREXATE. Patient recovered.

INJECTION SITE CELLULITIS : Rebif Side Effects Report #5512406-8
REBIF problem was reported by a Consumer or non-health professional from UNITED STATES on Oct 29, 2007. Female patient, 16 years of age, weighting 235.9 lb, was diagnosed with off label use and was treated with REBIF. After drug was administered, patient experienced the following problems/side effects: injection site cellulitis, injection site ulcer, . REBIF dosage: unknown. Patient was hospitalized. Patient recovered.

INJECTION SITE CELLULITIS : Faslodex Side Effects Report #5520012-4
Health Professional from UNITED STATES reported FASLODEX problem on Nov 13, 2007. Female patient, weighting 318.6 lb, was diagnosed with breast cancer metastatic and was treated with FASLODEX. After drug was administered, patient experienced the following problems/side effects: injection site cellulitis, . FASLODEX dosage: unknown. Patient recovered.

INJECTION SITE CELLULITIS : Rebif Side Effects Report #5521082-X
REBIF problem was reported by a Physician from UNITED STATES on Nov 02, 2007. Male patient, 36 years of age, weighting 190.0 lb, was diagnosed with multiple sclerosis and was treated with REBIF. After drug was administered, patient experienced the following problems/side effects: injection site cellulitis, wound secretion, . REBIF dosage: unknown. Patient was hospitalized. Patient recovered.

INJECTION SITE CELLULITIS : Betaseron Side Effects Report #5523907-0
Consumer or non-health professional from UNITED STATES reported BETASERON problem on Nov 20, 2007. Female patient, 49 years of age, was diagnosed with relapsing-remitting multiple sclerosis and was treated with BETASERON. After drug was administered, patient experienced the following problems/side effects: injection site cellulitis, open wound, . BETASERON dosage: unknown. Patient recovered.

INJECTION SITE CELLULITIS : Risperdal Side Effects Report #5480639-5
RISPERDAL problem was reported by a Health Professional from UNITED STATES on Oct 04, 2007. Male patient was diagnosed with psychotic disorder and was treated with RISPERDAL. After drug was administered, patient experienced the following problems/side effects: injection site cellulitis, . RISPERDAL dosage: unknown. During the same period patient was treated with COGENTIN. Patient recovered.

INJECTION SITE CELLULITIS : Hydroxyzine Side Effects Report #5483750-8
Health Professional from UNITED STATES reported HYDROXYZINE problem on Sept 19, 2007. Female patient, 70 years of age, weighting 138.0 lb, was diagnosed with migraine, nausea and was treated with HYDROXYZINE. After drug was administered, patient experienced the following problems/side effects: injection site cellulitis, injection site discharge, injection site haemorrhage, . HYDROXYZINE dosage: 100 MG INTRAMUSCULAR. Patient recovered.

INJECTION SITE CELLULITIS : Betaseron Side Effects Report #5493521-4
BETASERON problem was reported by a Consumer or non-health professional from UNITED STATES on Oct 10, 2007. Female patient, 44 years of age, weighting 116.0 lb, was diagnosed with relapsing-remitting multiple sclerosis and was treated with BETASERON. After drug was administered, patient experienced the following problems/side effects: injection site cellulitis, . BETASERON dosage: unknown. During the same period patient was treated with BACLOFEN, ESTRADIOL, LOVASTATIN, DETROL. Patient was hospitalized. Patient recovered.

INJECTION SITE CELLULITIS : Clindamycin Side Effects Report #5449372-X
Physician from INDIA reported CLINDAMYCIN problem on Aug 30, 2007. Male patient, 60 years of age, was treated with CLINDAMYCIN. After drug was administered, patient experienced the following problems/side effects: injection site cellulitis, injection site erythema, injection site pain, . CLINDAMYCIN dosage: unknown. Patient recovered.

INJECTION SITE CELLULITIS : Delestrogen Side Effects Report #5413258-7
DELESTROGEN problem was reported by a Pharmacist from UNITED STATES on Aug 07, 2006. Female patient was treated with DELESTROGEN. After drug was administered, patient experienced the following problems/side effects: injection site cellulitis, nausea, vomiting, . DELESTROGEN dosage: 5 ML, SINGLE. Patient recovered.

INJECTION SITE CELLULITIS : Hydroxyzineectio Side Effects Report #5413593-2
Health Professional from UNITED STATES reported HYDROXYZINEECTION problem on July 30, 2007. Female patient, 70 years of age, was treated with HYDROXYZINEECTION. After drug was administered, patient experienced the following problems/side effects: injection site cellulitis, . HYDROXYZINEECTION dosage: unknown. Patient recovered.

INJECTION SITE CELLULITIS : Clindamycin Side Effects Report #5427972-0
CLINDAMYCIN problem was reported by a Physician from INDIA on Aug 16, 2007. Male patient, 60 years of age, was treated with CLINDAMYCIN. After drug was administered, patient experienced the following problems/side effects: injection site cellulitis, injection site erythema, injection site pain, . CLINDAMYCIN dosage: unknown. Patient recovered.

INJECTION SITE CELLULITIS : Raptiva Side Effects Report #5381695-5
Health Professional from UNITED STATES reported RAPTIVA problem on July 05, 2007. Female patient was diagnosed with psoriasis and was treated with RAPTIVA. After drug was administered, patient experienced the following problems/side effects: injection site cellulitis, . RAPTIVA dosage: 1ML WEEKLY SQ. Patient recovered.

INJECTION SITE CELLULITIS : Sandostatin Side Effects Report #5388916-3
SANDOSTATIN LAR problem was reported by a Physician from UNITED STATES on July 10, 2007. Female patient, 91 years of age, weighting 168.0 lb, was diagnosed with carcinoid syndrome and was treated with SANDOSTATIN LAR. After drug was administered, patient experienced the following problems/side effects: injection site cellulitis, pyrexia, sepsis, . SANDOSTATIN LAR dosage: unknown. Patient recovered.

INJECTION SITE CELLULITIS : Betaseron Side Effects Report #5394579-3
Consumer or non-health professional from UNITED STATES reported BETASERON problem on July 10, 2007. Female patient, 49 years of age, was diagnosed with relapsing-remitting multiple sclerosis and was treated with BETASERON. After drug was administered, patient experienced the following problems/side effects: injection site cellulitis, open wound, . BETASERON dosage: unknown. Patient recovered.

INJECTION SITE CELLULITIS : Byetta Side Effects Report #5443811-6
BYETTA problem was reported by a Physician from UNITED STATES on June 05, 2007. Female patient was treated with BYETTA. After drug was administered, patient experienced the following problems/side effects: injection site cellulitis, urticaria, . BYETTA dosage: unknown. During the same period patient was treated with EXENATIDE PEN. Patient recovered.

INJECTION SITE CELLULITIS : Raptiva Side Effects Report #5381695-5
Health Professional from UNITED STATES reported RAPTIVA problem on July 05, 2007. Female patient was diagnosed with psoriasis and was treated with RAPTIVA. After drug was administered, patient experienced the following problems/side effects: injection site cellulitis, . RAPTIVA dosage: 1ML WEEKLY SQ. Patient recovered.

INJECTION SITE CELLULITIS : Sandostatin Side Effects Report #5388916-3
SANDOSTATIN LAR problem was reported by a Physician from UNITED STATES on July 10, 2007. Female patient, 91 years of age, weighting 168.0 lb, was diagnosed with carcinoid syndrome and was treated with SANDOSTATIN LAR. After drug was administered, patient experienced the following problems/side effects: injection site cellulitis, pyrexia, sepsis, . SANDOSTATIN LAR dosage: unknown. Patient recovered.

INJECTION SITE CELLULITIS : Betaseron Side Effects Report #5394579-3
Consumer or non-health professional from UNITED STATES reported BETASERON problem on July 10, 2007. Female patient, 49 years of age, was diagnosed with relapsing-remitting multiple sclerosis and was treated with BETASERON. After drug was administered, patient experienced the following problems/side effects: injection site cellulitis, open wound, . BETASERON dosage: unknown. Patient recovered.

INJECTION SITE CELLULITIS : Byetta Side Effects Report #5443811-6
BYETTA problem was reported by a Physician from UNITED STATES on June 05, 2007. Female patient was treated with BYETTA. After drug was administered, patient experienced the following problems/side effects: injection site cellulitis, urticaria, . BYETTA dosage: unknown. During the same period patient was treated with EXENATIDE PEN. Patient recovered.

INJECTION SITE CELLULITIS : Betaseron Side Effects Report #5687883-2
Consumer or non-health professional from UNITED STATES reported BETASERON problem on Mar 19, 2008. Male patient, 57 years of age, was diagnosed with secondary progressive multiple sclerosis and was treated with BETASERON. After drug was administered, patient experienced the following problems/side effects: cellulitis, injection site cellulitis, injection site discolouration, injection site reaction, thrombosis, . BETASERON dosage: unknown. Patient was hospitalized. Patient recovered.

INJECTION SITE CELLULITIS : Rebif Side Effects Report #5691820-4
REBIF problem was reported by a Health Professional from UNITED STATES on Mar 18, 2008. Female patient, 40 years of age, was diagnosed with multiple sclerosis and was treated with REBIF. After drug was administered, patient experienced the following problems/side effects: influenza like illness, injection site cellulitis, migraine, muscle spasticity, nausea, nonspecific reaction, rash, . REBIF dosage: unknown. During the same period patient was treated with IMITREX. Patient was hospitalized. Patient recovered.

INJECTION SITE CELLULITIS : Dalteparin Side Effects Report #5633045-4
Health Professional from UNITED KINGDOM reported DALTEPARIN problem on Jan 30, 2008. Male patient, 70 years of age, was diagnosed with pulmonary embolism and was treated with DALTEPARIN. After drug was administered, patient experienced the following problems/side effects: cellulitis gangrenous, injection site cellulitis, thrombocytopenia, . DALTEPARIN dosage: unknown. During the same period patient was treated with FLUCONAZOLE, HALOPERIDOL, ACETAMINOPHEN, SALBUTAMOL, PIPERACILLIN AND TAZOBACTAM. Patient was hospitalized. Patient recovered.

INJECTION SITE CELLULITIS : Avonex Side Effects Report #5543268-0
AVONEX problem was reported by a Consumer or non-health professional from UNITED STATES on Nov 30, 2007. Female patient, 41 years of age, was diagnosed with multiple sclerosis and was treated with AVONEX. After drug was administered, patient experienced the following problems/side effects: injection site abscess, injection site cellulitis, . AVONEX dosage: unknown. Patient was hospitalized. Patient recovered.

INJECTION SITE CELLULITIS : Betaseron Side Effects Report #5505541-1
Physician from UNITED STATES reported BETASERON problem on Oct 24, 2007. Male patient, 71 years of age, weighting 178.0 lb, was diagnosed with multiple sclerosis and was treated with BETASERON. After drug was administered, patient experienced the following problems/side effects: infection, injection site cellulitis, thrombophlebitis, . BETASERON dosage: unknown. During the same period patient was treated with COUMADIN, NEXIUM, ASPIRIN, LASIX, RAZADYNE, ATIVAN, REGLAN. Patient was hospitalized. Patient recovered.

INJECTION SITE CELLULITIS : Rebif Side Effects Report #5522026-7
REBIF problem was reported by a Health Professional from UNITED STATES on Nov 02, 2007. Female patient, 52 years of age, weighting 150.0 lb, was diagnosed with multiple sclerosis and was treated with REBIF. After drug was administered, patient experienced the following problems/side effects: blood cholesterol increased, injection site cellulitis, . REBIF dosage: unknown. During the same period patient was treated with GABAPENTIN, POTASSIUM, LASIX, NORTRIPTYLINE, OXYCODONE, SERTRALINE. Patient was hospitalized. Patient recovered.

INJECTION SITE CELLULITIS : Rebif Side Effects Report #5486546-6
Physician from UNITED STATES reported REBIF problem on Oct 04, 2007. Female patient, 36 years of age, was diagnosed with multiple sclerosis and was treated with REBIF. After drug was administered, patient experienced the following problems/side effects: encephalitis viral, injection site cellulitis, . REBIF dosage: unknown. During the same period patient was treated with DULOXETINE, FOLIC ACID, VERAPAMIL CR. Patient was hospitalized. Patient died on 09/14/2007.

INJECTION SITE CELLULITIS : Betaseron Side Effects Report #5488897-8
BETASERON problem was reported by a Consumer or non-health professional from UNITED STATES on Oct 04, 2007. Male patient, 71 years of age, was diagnosed with multiple sclerosis and was treated with BETASERON. After drug was administered, patient experienced the following problems/side effects: infection, injection site cellulitis, . BETASERON dosage: unknown. Patient was hospitalized. Patient recovered.

INJECTION SITE CELLULITIS : Betaseron Side Effects Report #5499551-0
Consumer or non-health professional from UNITED STATES reported BETASERON problem on Oct 09, 2007. Female patient, 45 years of age, weighting 130.0 lb, was diagnosed with relapsing-remitting multiple sclerosis, fatigue, bladder disorder and was treated with BETASERON. After drug was administered, patient experienced the following problems/side effects: herpes zoster, injection site cellulitis, multiple sclerosis, . BETASERON dosage: unknown. During the same period patient was treated with CORTICOSTEROIDS, BACLOFEN, PROVIGIL, OXYTROL, ASCORBIC ACID. Patient was hospitalized. Patient recovered.

INJECTION SITE CELLULITIS : Rebif Side Effects Report #5450668-6
REBIF problem was reported by a Consumer or non-health professional from UNITED STATES on Aug 27, 2007. Female patient, 52 years of age, weighting 90.00 lb, was diagnosed with multiple sclerosis and was treated with REBIF. After drug was administered, patient experienced the following problems/side effects: gait disturbance, injection site cellulitis, . REBIF dosage: unknown. During the same period patient was treated with OXYBUTYNIN CHLORIDE, ZYRTEC. Patient was hospitalized. Patient recovered.

INJECTION SITE CELLULITIS : Betaseron Side Effects Report #5407774-1
Consumer or non-health professional from UNITED STATES reported BETASERON problem on July 31, 2007. Female patient, 45 years of age, was diagnosed with relapsing-remitting multiple sclerosis and was treated with BETASERON. After drug was administered, patient experienced the following problems/side effects: herpes zoster, injection site cellulitis, multiple sclerosis, . BETASERON dosage: unknown. Patient was hospitalized. Patient recovered.

INJECTION SITE CELLULITIS : Sandostatin Side Effects Report #5393275-6
SANDOSTATIN LAR problem was reported by a Physician from UNITED STATES on July 17, 2007. Female patient, 91 years of age, weighting 168.0 lb, was diagnosed with carcinoid syndrome and was treated with SANDOSTATIN LAR. After drug was administered, patient experienced the following problems/side effects: fatigue, injection site cellulitis, pyrexia, sepsis, . SANDOSTATIN LAR dosage: unknown. Patient was hospitalized. Patient recovered.

INJECTION SITE CELLULITIS : Sandostatin Side Effects Report #5393275-6
Physician from UNITED STATES reported SANDOSTATIN LAR problem on July 17, 2007. Female patient, 91 years of age, weighting 168.0 lb, was diagnosed with carcinoid syndrome and was treated with SANDOSTATIN LAR. After drug was administered, patient experienced the following problems/side effects: fatigue, injection site cellulitis, pyrexia, sepsis, . SANDOSTATIN LAR dosage: unknown. Patient was hospitalized. Patient recovered.

INJECTION SITE CELLULITIS : Avonex Side Effects Report #5676720-8
AVONEX problem was reported by a Consumer or non-health professional from UNITED STATES on Mar 03, 2008. Female patient, 44 years of age, was diagnosed with multiple sclerosis and was treated with AVONEX. After drug was administered, patient experienced the following problems/side effects: deep vein thrombosis, influenza like illness, injection site cellulitis, injection site haematoma, injection site induration, . AVONEX dosage: unknown. During the same period patient was treated with MOTRIN, ALLEGRA, TESSALON, TOPAMAX, XANAX, KEPPRA, ZANAFLEX, VITAMIN AND MINERAL PRENATAL SUPPLEMENT W. Patient was hospitalized. Patient recovered.

INJECTION SITE CELLULITIS : Betaseron Side Effects Report #5677279-1
Consumer or non-health professional from UNITED STATES reported BETASERON problem on Mar 13, 2008. Female patient, 45 years of age, weighting 130.1 lb, was diagnosed with relapsing-remitting multiple sclerosis, muscle spasms, fatigue, urinary incontinence, bladder disorder and was treated with BETASERON. After drug was administered, patient experienced the following problems/side effects: gait disturbance, herpes zoster, injection site cellulitis, injection site erythema, injection site infection, injection site mass, injection site pain, multiple sclerosis, . BETASERON dosage: unknown. During the same period patient was treated with BACLOFEN, PROVIGIL, OXYTROL, ASCORBIC ACID. Patient was hospitalized. Patient recovered.

INJECTION SITE CELLULITIS : Rebif Side Effects Report #5512395-6
REBIF problem was reported by a Physician from UNITED STATES on Oct 29, 2007. Female patient, 38 years of age, was diagnosed with multiple sclerosis and was treated with REBIF. After drug was administered, patient experienced the following problems/side effects: hepatic enzyme increased, influenza like illness, injection site cellulitis, insomnia, . REBIF dosage: unknown. During the same period patient was treated with FLU SHOT. Patient was hospitalized. Patient recovered.

INJECTION SITE CELLULITIS : Rebif Side Effects Report #5481141-7
Health Professional from UNITED STATES reported REBIF problem on Sept 20, 2007. Male patient, 42 years of age, was diagnosed with multiple sclerosis and was treated with REBIF. After drug was administered, patient experienced the following problems/side effects: injection site abscess, injection site cellulitis, . REBIF dosage: unknown. Patient was hospitalized. Patient recovered.

INJECTION SITE CELLULITIS : Rebif Side Effects Report #5481992-9
REBIF problem was reported by a Consumer or non-health professional from UNITED STATES on Sept 21, 2007. Male patient, 78 years of age, was diagnosed with multiple sclerosis and was treated with REBIF. After drug was administered, patient experienced the following problems/side effects: asthenia, dehydration, injection site cellulitis, injection site erythema, malaise, scar, skin discolouration, . REBIF dosage: unknown. Patient was hospitalized. Patient recovered.

INJECTION SITE CELLULITIS : Rebif Side Effects Report #5501326-0
Physician from UNITED STATES reported REBIF problem on Oct 12, 2007. Male patient, 42 years of age, was diagnosed with multiple sclerosis and was treated with REBIF. After drug was administered, patient experienced the following problems/side effects: injection site abscess, injection site cellulitis, . REBIF dosage: unknown. Patient was hospitalized. Patient recovered.

PatientsVille.com does not provide medical advice, diagnosis or treatment. The information contained on PatientsVille.com site has not been scientifically or otherwise verified as to a cause and effect relationship and cannot be used to estimate the incidence of adverse drug reactions or for establishing or changing of patient treatments.


Thank you for visiting Patientsville.com. We hope you found our information about INJECTION SITE CELLULITIS side effects helpful. The material on this site is for informational purposes only, and is not a substitute for medical advice, diagnosis or treatment provided by a qualified health care provider. Thank you for visiting Patientsville.net. Hope you enjoyed finding information on medications and found answers to Your Questions about INJECTION SITE CELLULITIS